Je veux savoir à propos de…

Federal Register / Vol. 86, No. 24 / Monday, February 8, 2021 / Notices telephone number: 2025641667;
email address: edelstein.rebecca@
epa.gov.
For general information contact: The TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: 202 554
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:

substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment. This document presents statements of findings made by EPA
during the period from September 1, 2019 to December 31, 2019.
III. What is the Agencys authority for taking this action?

TSCA section 5a3 requires EPA to review a TSCA section 5a notice and make one of the following specific A. Does this action apply to me?
findings:
This action is directed to the public The chemical substance or in general. As such, the Agency has not significant new use presents an attempted to describe the specific unreasonable risk of injury to health or entities that this action may apply to.
the environment;
Although others may be affected, this The information available to EPA is action applies directly to the submitters insufficient to permit a reasoned of the PMNs addressed in this action.
evaluation of the health and B. How can I get copies of this document environmental effects of the chemical substance or significant new use;
and other related information?
The information available to EPA is The docket for this action, identified insufficient to permit a reasoned by docket identification ID number EPAHQOPPT20190271, is available evaluation of the health and environmental effects and the chemical at http www.regulations.gov or at the substance or significant new use may Office of Pollution Prevention and present an unreasonable risk of injury to Toxics Docket OPPT Docket, health or the environment;
Environmental Protection Agency The chemical substance is or will Docket Center EPA/DC, West William be produced in substantial quantities, Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW, Washington, DC. and such substance either enters or may reasonably be anticipated to enter the The Public Reading Room is open from environment in substantial quantities or 8:30 a.m. to 4:30 p.m., Monday through there is or may be significant or Friday, excluding legal holidays. The substantial human exposure to the telephone number for the Public substance; or Reading Room is 202 5661744, and The chemical substance or the telephone number for the OPPT
significant new use is not likely to Docket is 202 5660280.
present an unreasonable risk of injury to Due to the public health concerns health or the environment.
related to COVID19, the EPA Docket Unreasonable risk findings must be Center EPA/DC and Reading Room is made without consideration of costs or closed to visitors with limited other non-risk factors, including an exceptions. The staff continues to unreasonable risk to a potentially provide remote customer service via exposed or susceptible subpopulation email, phone, and webform. For the identified as relevant under the latest status information on EPA/DC
services and docket access, visit https conditions of use. The term conditions of use is defined in TSCA section 3 to www.epa.gov/dockets.
mean the circumstances, as determined II. What action is the Agency taking?
by the Administrator, under which a chemical substance is intended, known, This document lists the statements of or reasonably foreseen to be findings made by EPA after review of manufactured, processed, distributed in notices submitted under TSCA section commerce, used, or disposed of.
5a that certain new chemical I. General Information
jbell on DSKJLSW7X2PROD with NOTICES

EPA case No.

EPA is required under TSCA section 5g to publish in the Federal Register a statement of its findings after its review of a TSCA section 5a notice when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to PMNs, MCANs, and SNUNs submitted to EPA under TSCA section 5.
Anyone who plans to manufacture which includes import a new chemical substance for a non-exempt commercial purpose and any manufacturer or processor wishing to engage in a use of a chemical substance designated by EPA
as a significant new use must submit a notice to EPA at least 90 days before commencing manufacture of the new chemical substance or before engaging in the significant new use.
The submitter of a notice to EPA for which EPA has made a finding of not likely to present an unreasonable risk of injury to health or the environment may commence manufacture of the chemical substance or manufacture or processing for the significant new use notwithstanding any remaining portion of the applicable review period.
IV. Statements of Administrator Findings Under TSCA Section 5a3C
In this unit, EPA provides the following information to the extent that such information is not claimed as Confidential Business Information CBI on the PMNs, MCANs and SNUNs for which, during this period, EPA has made findings under TSCA
section 5a3C that the new chemical substances or significant new uses are not likely to present an unreasonable risk of injury to health or the environment:
EPA case number assigned to the TSCA section 5a notice.
Chemical identity generic name, if the specific name is claimed as CBI.
Website address to EPAs decision document describing the basis of the not likely to present an unreasonable risk finding made by EPA under TSCA
section 5a3C.

Chemical identity
Website address
J190024, J19
0025.

Biofuel producing Saccharomyces cerevisiae modified, genetically stable generic name.

P150632

Mixed amine salt generic name

VerDate Sep<11>2014

20:48 Feb 05, 2021

Jkt 253001

PO 00000

Frm 00046

Fmt 4703

8623

Sfmt 4703

E:FRFM08FEN1.SGM

https www.epa.gov/reviewing-newchemicals-under-toxic-substancescontrol-act-tsca/tsca-section-5a3c-determination-296.
https www.epa.gov/reviewing-newchemicals-under-toxic-substancescontrol-act-tsca/tsca-section-5a3c-determination-327.

08FEN1